Introduction {#s1}
============

Pulmonary rehabilitation (PR) is a multidisciplinary therapeutic approach including exercise training that aims to restore patients\' independent functioning, decrease disability, relieve symptoms and enhance quality of life \[[@C1], [@C2]\]. Its integral role in preparing patients with advanced lung disease for lung transplantation (LTx), facilitating their recovery and optimising long-term benefits in the post-transplant phase has already been well documented \[[@C3]--[@C7]\]. Despite vast improvement in lung function, a number of LTx recipients may present persisting impairment in exercise capacity and skeletal muscle function \[[@C8]--[@C10]\] due to reduced capacity for skeletal muscle oxidative metabolism, extended hospital and intensive care unit stay, prolonged body inactivity, immunosuppressant medication, and episodes of allograft rejection \[[@C11]--[@C13]\]. Moreover, LTx seems to be associated with cognitive decline in a subset of older patients \[[@C14]\], likely due to immunosuppressant toxicity \[[@C13]--[@C15]\] and/or central nervous system events \[[@C16]\]. Given the fact that transplantation is limited by the shortage of available organ donors, patients with chronic obstructive pulmonary disease (COPD) selected to undergo LTx should be candidates with an expected good long-term outcome \[[@C17]--[@C20]\].

Intact cognitive function is a critical prerequisite for optimal post-operative handling, in particular when dealing with a complex drug regimen and decision-making abilities \[[@C21], [@C22]\], whereas reduced cognitive function after LTx could undermine the goals of LTx and result in poor long-term outcomes \[[@C23]\]. Evidence has shown that 39% of cognitively intact patients who underwent LTx exhibited cognitive deficits after surgery, when cognitive function was assessed at hospital discharge \[[@C14], [@C23]\]. This could further suggest the important role of PR in cognitive status for optimising the long-term outcomes in LTx \[[@C24]\].

To date, the beneficial effects of PR programmes in the post-transplant phase, especially in cognitive function, which is the primary outcome of the current study, are not clear and merit further investigation. The objectives of this pilot study were to determine the feasibility of the current study protocol, and to investigate changes in lung function, exercise capacity and cognitive function after a comprehensive 3-week PR programme in COPD LTx recipients. In addition to the expected improvements in functional status, we assumed that PR provides COPD LTx recipients with a beneficial effect on cognitive function in the post-transplant phase.

Methods {#s2}
=======

Study design and patients {#s2a}
-------------------------

LTx recipients at least 1 month following LTx and referred to PR at the Schoen Klinik Berchtesgadener Land (Schoenau am Koenigssee, Germany) were asked to participate in this pilot study. A comprehensive assessment of neurocognitive function was performed on PR admission and at discharge. These measurements were part of a larger exercise trial in LTx recipients \[[@C25]\] and were approved by the Bavarian Ethics Committee (approval 11051). Participants met the following inclusion criteria: 1) single or bilateral LTx for COPD and 2) stable health condition (≥4 weeks). Exclusion criteria were: 1) post-operative complications (pathological: acute organ rejection, infection, persisting pulmonary oedema and cardiovascular events; surgical: wound dehiscence) and 2) neurological or psychiatric conditions.

Assessment {#s2b}
----------

As part of the pre-PR clinical routine assessment, LTx recipients underwent physical examination, anthropometric and lung function measurements, and blood gas analysis, and their medical history was taken. Additionally, they completed self-administered questionnaires (Hospital Anxiety and Depression Scale (HADS) and Chronic Respiratory Disease Questionnaire (CRQ)) and performed the 6-min walk test (6MWT) according to international guidelines \[[@C26], [@C27]\]. Furthermore, they underwent a comprehensive cognitive function assessment by a complete neuropsychological testing battery ([figure 1](#F1){ref-type="fig"} and see [supplementary material](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials) for details), including the Intelligence Quotient (IQ) test \[[@C28]\] and the Stroop colour-word test \[[@C29]\]. After a 3-week PR programme, the measurements were repeated under the same conditions (post-PR assessment) to detect differences between pre- and post-PR values ([figure 1](#F1){ref-type="fig"}).

![Flowchart of study methodology. PR: pulmonary rehabilitation.](00060-2019.01){#F1}

PR programme {#s2c}
------------

Exercise training was a core component in the PR \[[@C30]\], performed 5--6 times per week (at least 15 sessions), with each session lasting ∼50 min, plus 30 min training of daily living activities. Patients performed supervised exercise on stationary bicycles, treadmills and fitness equipment during each session. Workload and duration were progressively increased as tolerated for the bicycles, treadmills and fitness equipment, reaching exercise at 70% of peak work rate for 20 min. In addition to the aerobic training, patients performed lightweight body training with upper and lower limb strengthening exercises. Exercise intensity was progressed with the aim of reaching dyspnoea and leg fatigue scores of 5 and 6 on a 10-point Borg scale, respectively (see [supplementary table S2](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials) for more details).

Statistical analysis {#s2d}
--------------------

All statistical analyses were carried out using SPSS Statistics version 19.0 (IBM, Armonk, NY, USA). Data are presented as mean with standard deviation or proportion, as appropriate. Paired-sample t-tests were used to detect differences between pre- and post-PR measurements; Pearson\'s correlation coefficient (r) was used to assess bivariate relationships. Effect size (ES) was calculated by taking the mean change between pre- and post-PR values and dividing it by the pooled standard deviation of both measurements (Cohen\'s *d*) \[[@C31]\]. Higher values of ES represent higher responsiveness, with scores greater than 0.20, 0.50 and 0.80 representing "small", "moderate" and "large" changes, respectively \[[@C32]\]. The average value of different ES means derived from several domain-specific cognitive evaluation outcomes was tested against zero (test value=0) by the one-sample t-test to detect a directional trend significance. Changes in lung and cognitive function and exercise capacity after PR were estimated in the total patient population and after stratification for LTx type (single *versus* bilateral) and sex (male *versus* female). A two-sided level of significance was set at p≤0.05.

Results {#s3}
=======

Feasibility of the study protocol {#s3a}
---------------------------------

A researcher involved in this study was responsible for the recruitment, which usually required ∼5--10 min for explaining the research project and obtaining consent from the participants. Initially, self-completed questionnaires (HADS and CRQ) were given to participants, but there were some items that they missed, possibly because they skipped and forgot the question or were not sure of the answer. Moreover, some participants faced difficulties in understanding their tasks in cognitive tests. This problem was overcome after explaining the tests to the participant multiple times until we were confident that they had fully understood the tasks and the results of each test reflected more the pure cognitive performance rather than confusion derived from a poor understanding of the cognitive test tasks. Participants needed ∼90 min to perform all the cognitive tests, including a 10 min break ([figure 1](#F1){ref-type="fig"}), while most of the tasks/test questions were not standardised by time. The long duration of our comprehensive cognitive testing battery caused mental fatigue to the participants; however, the large number of cognitive tests was necessary in order to have a complete multiple domain-specific cognitive evaluation. We did not have any dropout during the cognitive function tests, the 6MWTs or the PR programme. The exclusion criteria of post-operative complications and neurological or psychiatric conditions were set to eliminate the possibility of an adverse event during exercise and to secure the study in better reflecting PR effectiveness in COPD LTx recipients.

Recruitment of subjects {#s3b}
-----------------------

24 LTx recipients (age range 39--70 years; 42% female) were included in this study. They had normal range body mass index, mild airflow limitation, moderately reduced diffusing capacity of the lung for carbon monoxide (*D*~LCO~ \<60% predicted) and elevated unresolved hyperinflation (residual volume (RV)/total lung capacity (TLC) \>50% predicted). LTx recipients were characterised by mildly impaired health-related quality of life (rated by CRQ), with normal anxiety and depression levels (rated by HADS), while they had completed on average 8 years of education and presented a normal IQ score. The majority (67%) had undergone bilateral LTx for COPD, with 33% being diagnosed with α~1~-antitrypsin deficiency ([table 1](#TB1){ref-type="table"}).

###### 

Demographics and clinical characteristics of the lung transplantation (LTx) recipients

  --------------------------------- ------------
  **Subjects**                           24
  **Female**                          10 (42)
  **Age years**                       58.2±6.3
  **BMI kg·m^−2^**                    22.0±3.5
  **FEV~1~ % pred**                  75.4±22.0
  **FEV~1~/VC** **% pred**           75.0±14.1
  ***D*~LCO~** **% pred**            53.5±16.4
  **RV/TLC % pred**                  55.6±12.1
  **CRQ domain score**              
   Dyspnoea                           4.7±2.1
   Fatigue                            4.9±1.5
   Emotion                            5.5±1.4
   Mastery                            5.8±1.4
  **HADS domain score**             
   Anxiety                            4.4±4.2
   Depression                         3.8±3.5
  **Education years**                 8.0±2.6
  **IQ score**                       110.0±12.4
  **Single or bilateral LTx**       
   Single                              8 (33)
   Bilateral                          16 (67)
  **α~1~-antitrypsin deficiency**      8 (33)
  --------------------------------- ------------

Data are presented as n, n (%) or mean±[sd]{.smallcaps}. BMI: body mass index; FEV~1~: forced expiratory volume in 1 s; VC: vital capacity; *D*~LCO~: diffusing capacity of the lung for carbon monoxide; RV: residual volume; TLC: total lung capacity; CRQ: Chronic Respiratory Disease Questionnaire; HADS: Hospital Anxiety and Depression Scale; IQ: Intelligence Quotient.

Data entry and analysis {#s3c}
-----------------------

LTx recipients had impaired exercise capacity (6MWD \<350 m) with a moderate exercise-induced arterial oxygen saturation measured by pulse oximetry (*S*~pO~2~~) decline during the 6MWT (Δ*S*~pO~2~~ --3.9 percentage points), mild elevation in heart rate (ΔHR 21 beats·min^−1^), and weak physical condition as indicated by the low ratio of the distance--saturation product (DSP) and the limited ability to keep a continuous pace during the 6MWT (unintended stop point 340 m) ([table 2](#TB2){ref-type="table"}). In addition, LTx recipients demonstrated reduced cognitive performance in several clinical instruments of cognitive function assessment according to the respective normative values ([table 3](#TB3){ref-type="table"} and [supplementary figure S1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)). They presented reduced to average memory (Wechsler Memory Scales IV: Logical Memory I and II) and learning skills (California Verbal Learning Test tasks) as indicated by low scores, and poor performance in attention and flexibility (Test of Attentional Performance (TAP) battery: speed--accuracy index at the 25th percentile of normative values) with limited shared attention ability ([table 3](#TB3){ref-type="table"} and [supplementary figure S1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)). By contrast, LTx recipients presented a normal IQ (score 110), normative range values in psychomotor speed (Stroop colour-word test values 40--60), average visuospatial and processing speed/praxis ability (TAP and Clock-Drawing Test scores in the 25th to 75th percentile of norms), and average range behavioural activation (Behavioural Assessment of the Dysexecutive Syndrome) ([table 3](#TB3){ref-type="table"} and [supplementary figure S1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)). Moreover, there were weak or no associations between cognitive function and mental health (HADS) as well as health status (CRQ) for the majority of the tests ([supplementary table S3](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)), while changes in cognitive function and changes in exercise capacity (6MWT) after the PR programme did not show any significant correlation ([supplementary figure S2](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)).

###### 

Lung function and exercise responses before and after the pulmonary rehabilitation (PR) programme in the 24 lung transplantation recipients

                                    **Pre-PR**   **Post-PR**   **Mean difference**   **ES**     **p-value**
  -------------------------------- ------------ ------------- --------------------- -------- ------------------
  **FEV~1~ % pred**                 75.4±22.0     76.6±22.7          1.2±5.2          0.06    [ns]{.smallcaps}
  ***D*~LCO~** **% pred**           53.5±16.4     57.8±17.5          4.3±4.6          0.27         0.012
  **RV/TLC % pred**                 55.6±12.1     53.3±11.9         −2.3±3.2          0.20         0.017
  **Exercise data**                                                                          
   6MWD m                            346±127       432±113            86±77           0.73        \<0.001
   6MWD % pred                      51.0±17.7     64.0±14.7         13.0±10.6         0.81        \<0.001
   *S*~pO~2~~ baseline %             96.5±1.4     97.0±1.4           0.5±1.5          0.36    [ns]{.smallcaps}
   *S*~pO~2~~ end-exercise %         92.6±6.3     93.9±3.9           1.3±5.1          0.08    [ns]{.smallcaps}
   Δ*S*~pO~2~~ percentage points     −3.9±5.7     −3.1±3.3           0.8±4.8          0.17    [ns]{.smallcaps}
   HR baseline beats·min^−1^          87±13         87±12             0±12            0.01    [ns]{.smallcaps}
   HR end-exercise beats·min^−1^      108±18       116±17             8±10            0.47         0.002
   ΔHR beats·min^−1^                  21±19         29±14             8±15            0.49         0.029
   DSP m%                            326±124       406±109           80±63.9          0.70        \<0.001
   Unintended stop point m           340±130       424±115           84±75.6          0.70        \<0.001

Data are presented as mean±[sd,]{.smallcaps} unless otherwise stated. ES: effect size; FEV~1~: forced expiratory volume in 1 s; *D*~LCO~: diffusing capacity of the lung for carbon monoxide; RV: residual volume; TLC: total lung capacity; 6MWD: 6-min walk distance; *S*~pO~2~~: arterial oxygen saturation measured by pulse oximetry; HR: heart rate; DSP: distance--saturation product. Level of significance was set at p≤0.05; [ns]{.smallcaps}: nonsignificant.

###### 

Cognitive function assessment before and after the pulmonary rehabilitation (PR) programme in the 24 lung transplantation recipients

  **Domain-specific evaluation**           **Pre-PR**   **Post-PR**   **Mean difference**   **ES**     **p-value**
  --------------------------------------- ------------ ------------- --------------------- -------- ------------------
  **Memory ability**                                                                                
   WMS Logical Memory I score               11.0±2.7     12.9±2.4           1.9±2.7          0.76         0.004
   WMS Logical Memory II score              9.7±3.0      11.9±3.8           2.2±2.9          0.66         0.003
   CVLT Free recall: list 1 score          30.4±28.2     51.7±34.7         21.3±28.5         0.69         0.003
   CVLT Free recall: list 2 score          33.3±31.1     47.8±34.1         14.5±26.0         0.45         0.022
   CVLT Recall with help: list 1 score     38.7±26.6     50.9±33.6         12.2±31.6         0.41    [ns]{.smallcaps}
   CVLT Recall with help: list 2 score     38.5±28.7     50.7±30.9         12.2±23.9         0.42         0.034
   CVLT Repeating errors score             68.6±21.8     70.9±27.5         2.3±26.4          0.09    [ns]{.smallcaps}
   Composite score                         32.7±29.2     42.1±33.6         9.3±23.6          0.31         0.001
  **Learning skills**                                                                               
   CVLT Learning ability %                 33.4±31.8     57.1±33.9         23.7±28.2         0.74         0.020
   CVLT Passage 1 %                        32.1±23.4     61.0±34.2         28.9±34.9         1.00         0.001
   CVLT Passage 5 %                        20.8±25.4     40.3±34.6         19.5±24.2         0.66         0.001
   CVLT List B %                           23.0±28.4     25.6±22.0         2.6±28.2          0.10    [ns]{.smallcaps}
   Composite score                         27.5±27.5     46.4±34.2         18.9±30.4         0.62         0.001
  **Attention and flexibility**                                                                     
   TAP Speed/accuracy %                    56.2±31.5     56.5±32.9         0.3±27.6          0.01    [ns]{.smallcaps}
   TAP Shared attention ability %          50.4±28.3     45.8±28.9         −4.6±33.0         0.16    [ns]{.smallcaps}
   Composite score                         54.1±29.8     51.3±31.1         −2.8±30.1         0.09    [ns]{.smallcaps}
  **Visuospatial and processing speed**                                                             
   TMT-A score                             42.8±14.9     38.3±20.1         −4.5±27.9         0.26    [ns]{.smallcaps}
   TMT-B score                             99.0±52.2     84.9±35.2        −14.1±36.9         0.32    [ns]{.smallcaps}
   Composite score                         70.9±47.4     61.6±36.9         −9.3±32.7         0.22    [ns]{.smallcaps}
  **Visuospatial and praxis ability**                                                               
   CDT Clock test score                     13.1±1.2     13.1±1.3           0.0±0.7          0.01    [ns]{.smallcaps}
  **Psychomotor speed**                                                                             
   Stroop colour-word read points           48.5±7.5     51.3±7.7           2.8±4.9          0.38         0.015
   Stroop colour recognition points         54.4±8.1     57.4±9.3           3.0±6.0          0.35         0.027
   Stroop interference points               55.0±9.7     55.3±9.3           0.3±7.7          0.03    [ns]{.smallcaps}
   Composite score                          52.6±8.8     54.6±9.0           2.0±6.3          0.23         0.012
  **Behavioural activation**                                                                        
   BADS version 1 score                     6.8±1.6       6.1±1.6          −0.7±2.6          0.42    [ns]{.smallcaps}
   BADS version 2 score                     7.6±0.7       7.6±0.7          −0.0±0.9          0.01    [ns]{.smallcaps}
   Composite score                          7.1±1.3       6.8±1.4          −0.3±1.9          0.23    [ns]{.smallcaps}

Data are presented as mean±[sd,]{.smallcaps} unless otherwise stated. ES: effect size; WMS: Wechsler Memory Scales IV; CVLT: California Verbal Learning Test; TAP: Test of Attentional Performance; TMT: Trail Making Test; CDT: Clock-Drawing Test; BADS: Behavioural Assessment of the Dysexecutive Syndrome. Positive values (better scores) determine improvement for memory ability, learning skills, psychomotor speed (points) and visuospatial/praxis ability, while negative values (faster responses) determine improvement (expressed as positive ES) for behavioural activation, visuospatial and processing speed, and attention/flexibility. Level of significance was set at p≤0.05; [ns]{.smallcaps}: nonsignificant.

Effect of PR on lung functioning and exercise responses {#s3d}
-------------------------------------------------------

Overall, LTx recipients improved lung diffusing capacity (*D*~LCO~) and static hyperinflation (RV/TLC) after the PR intervention, demonstrating small but significant improvements in lung function (Δ*D*~LCO~ 4.3%; p=0.012 and ΔRV/TLC −2.3%; p=0.017) ([table 2](#TB2){ref-type="table"}). Moreover, substantial increases in exercise capacity (Δ6MWD 86 m; p\<0.001) and HR peak during the 6MWT (ΔHR 8 beats·min^−1^; p=0.029) were observed after the PR programme. The minimum clinically important difference for the 6MWD (≥30 m) was reached or surpassed by 71% of LTx recipients. Furthermore, they significantly increased the 6MWT-derived variables of DSP (ΔDSP 80 m%; p\<0.001) and unintended stop point during the 6MWT (distance where the first pause to rest was usually noticed: 84 m; p\<0.001) ([table 2](#TB2){ref-type="table"}). A strong correlation between improvements in DSP and unintended stop points (r=0.79; p\<0.001) was detected.

Effect of PR on cognitive functioning {#s3e}
-------------------------------------

Overall, LTx recipients demonstrated improvements in cognitive function according to several domain-specific cognitive tests after the PR programme ([figure 2](#F2){ref-type="fig"}). Specifically, they presented better performance in 10 out of 20 cognitive tests (50%), demonstrating small to large significant improvements (ES range 0.23--1.00; all p≤0.34) ([table 3](#TB3){ref-type="table"}). Cognitive domains of learning, memory and psychomotor speed showed significant small to moderate improvements (ES 0.62, 0.31 and 0.23, respectively), whereas the global performance (composite scores) for the rest did not present any significant change in response to PR ([table 3](#TB3){ref-type="table"} and [figure 2a](#F2){ref-type="fig"}).

![The effects of pulmonary rehabilitation on cognitive function in lung transplantation (LTx) recipients: a) total population (n=24), b) single LTx recipients (n=8 (33%)), c) bilateral LTx recipients (n=16 (66%)), d) male LTx recipients (n=14 (58%)) and e) female LTx recipients (n=10 (42%)). The dashed line indicates the mean effect size. \*: p\<0.05; \*\*: p\<0.001; [ns]{.smallcaps}: nonsignificant.](00060-2019.02){#F2}

*A posteriori* analyses {#s3f}
-----------------------

After stratification for the type of LTx (single or bilateral), changes in the 6MWT \[[@C19]\] and the assessed cognitive domains were studied. We demonstrated that PR is particularly beneficial for exercise capacity (6MWD) and cognitive function (learning skills, memory ability and psychomotor speed) during the post-transplant phase for both single and bilateral LTx recipients ([figure 2b](#F2){ref-type="fig"} and c). Although similar improvements in the 6MWD were recorded for both single and bilateral LTx recipients (63±54 *versus* 90±76 m; p=0.38), differences in cognitive performance on specific domains were detected. Bilateral LTx recipients improved to a greater extent in the domains of learning skills and memory, demonstrating moderate improvements compared with single LTx recipients who obtained smaller benefits ([figure 2b](#F2){ref-type="fig"} and c). However, single LTx recipients also presented small improvements in visuospatial and processing speed in contrast to bilateral LTx recipients ([figure 2b](#F2){ref-type="fig"} and c). Moreover, sex-related differences were also examined for PR effectiveness on cognitive function, demonstrating a beneficial effect on learning skills and memory, irrespective of sex. Nevertheless, small differences were observed in the domains of psychomotor speed and visuospatial processing in favour of males and females, respectively ([figure 2d](#F2){ref-type="fig"} and e).

Furthermore, we controlled for the influence of time interval to PR intervention (time between LTx and PR admission) on the improvement in cognitive function including as total all of the assessed cognitive domains (mean ES). Thereby, we report that the mean ES was significantly larger than zero after stratification for 1--2, 2--12 and \>12 months between LTx and the PR intervention, indicating directional trends for the beneficial PR effects on cognitive function ([table 4](#TB4){ref-type="table"}).

###### 

Mean effect sizes (ESs) for the relationship between the magnitude of improvement in cognitive function and the time interval between lung transplantation (LTx) and the pulmonary rehabilitation (PR) programme

  **Time to PR months**    **LTx recipients n**   **t**    **ES**     **p-value**  
  ----------------------- ---------------------- ------- ----------- ------------- -------
  **1--2**                          6             3.66    0.15±0.11   0.05--0.25    0.011
  **2--12**                         5             2.67    0.28±0.28   0.02--0.54    0.037
  **\>12**                          13            3.12    0.34±0.28   0.07--0.60    0.020

Mean ES was defined as the mean value of all cognitive domain ESs. A significant mean ES indicates a directional trend of global improvement in cognitive function.

Discussion {#s4}
==========

Initially, we report that the proposed study protocol is feasible according to this pilot study. With regard to the study outcomes, COPD LTx recipients gain significant benefits participating in PR with regard to lung and cognitive function as well as exercise capacity. Participation in a 3-week comprehensive PR programme was associated with multidimensional favourable effects on the post-transplant phase, which may lead to a faster and optimal recovery after surgery. Moreover, improvements in health and functional status, including less metabolic/cardiovascular morbidities \[[@C33]\] and greater exercise capacity \[[@C34]\], and an enhanced cognitive function associated with better adherence to therapy \[[@C35]\], after PR might improve long-term prognosis in COPD LTx recipients \[[@C33]--[@C37]\].

In COPD patients undergoing PR programmes, mild improvements in lung function and slower respiratory decline over time have been observed compared with patients treated only with medication \[[@C38], [@C39]\]. Comprehensive PR programmes including exercise training may improve skeletal muscle function, enhancing both respiratory and peripheral muscles \[[@C40]\], and increase *D*~LCO~ \[[@C41]\] and exercise capacity \[[@C42]\]. With regard to cognitive function, beneficial effects of PR programmes in COPD are well documented \[[@C24], [@C43], [@C44]\]. P[ereira]{.smallcaps} *et al*. \[[@C44]\] demonstrated that participation in a 3-month comprehensive PR programme in COPD led to significant improvements in a range of cognitive tests after adjusting for age, sex, tobacco consumption and educational level. Indeed, cognitive deficits may counteract with treatment course and fast recovery in LTx recipients, and result in poorer adherence to self-care practices and complex medication regimens \[[@C22], [@C45]\]. PR programmes during the post-transplant phase are important to improve lung function, exercise capacity and cognitive function \[[@C46]\].

Comparison with other studies {#s4a}
-----------------------------

In the current study, we found that LTx recipients significantly improved *D*~LCO~, static hyperinflation (RV/TLC) and functional capacity as assessed by the 6MWT after a comprehensive 3-week PR programme ([table 2](#TB2){ref-type="table"}). In terms of exercise tolerance, the impaired baseline walking capacity (\<350 m) in LTx recipients as a consequence of the prior COPD condition, poor health status and extended hospital unit stay along with prolonged sedentary time was increased by 86 m on PR discharge. This large gain is similar to the finding of M[unro]{.smallcaps} *et al*. \[[@C47]\], who reported an increase of 95 m after a 7-week outpatient post-LTx PR programme in lung disease LTx recipients. Despite the longer duration of the PR programme in the M[unro]{.smallcaps} *et al*. \[[@C47]\] study, the observed 6MWD increase in response to PR was comparable. Plausible explanations could be that our LTx patients were more debilitated at baseline (mean 6MWD 346 *versus* 451 m) and that our 3-week inpatient PR programme was comparatively more intensive. Indeed, lower baseline walking capacity is associated with higher increases in 6MWD after PR \[[@C48]--[@C50]\]. The 6MWD increase in our LTx recipients (from 346 to 432 m; p\<0.001) might also indicate a better long-term prognosis as the walking threshold of ≤350 m, which is associated with higher risk of all-cause mortality \[[@C51], [@C52]\], was surpassed at PR discharge. Furthermore, LTx recipients reached higher HR levels as they were able to walk more in the 6MWT, with increased DSP and reduced unintended stop points during walking that might also advocate for better long-term prognosis ([table 2](#TB2){ref-type="table"}) \[[@C53]\].

Cognitive function performance of the studied LTx recipients was lower according to normative values ([supplementary figure S1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)), as expected due to cognitive deficits that are prevalent in some patients with end-stage COPD disease before and after LTx \[[@C54]\]. In addition, LTx-related factors such as prolonged sedentary time/inactivity and immunosuppressive drugs \[[@C13]--[@C15]\], which may have a negative impact on cognitive function, and the COPD-related pathology could further increase the risk for cognitive decline. Indeed, COPD patients with mild and advanced hypoxaemia tend to display progressively poorer performance on multiple cognitive domains, including perceptual learning, problem solving, memory, cognitive flexibility, planning, psychomotor speed and simple motor functions \[[@C55]--[@C57]\], while mild cognitive impairment is present in the majority of patients after LTx \[[@C58]\]. Furthermore, T[orres-]{.smallcaps}S[anchez]{.smallcaps} *et al*. \[[@C59]\] reported that verbal memory and learning constitute the second most commonly impaired cognitive domain in COPD, and D[odd]{.smallcaps} *et al*. \[[@C60]\] demonstrated weak or no association between cognitive function and mood, fatigue or health status. In accordance with these findings, memory and learning skills, next to attention ability, were also the most impaired cognitive domains in COPD LTx recipients, while we found only a weak or no association for the vast majority of cognitive tests with the mental (HADS) and health (CRQ) status tests ([supplementary table S3](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)).

In the current study, we report for the first time that LTx recipients obtained significant benefits in cognitive function after PR intervention as assessed by multidomain cognitive tests ([figure 2a](#F2){ref-type="fig"}). Engagement with a comprehensive PR programme including exercise training \[[@C30]\] may offer several physiological and psychological positive effects on cognitive function \[[@C61]\]. Consistent with previous reports, we found that COPD LTx recipients, who had poor performance in memory and executive skills, significantly improved the cognitive domains of learning, memory and psychomotor speed through their participation in PR ([figure 2a](#F2){ref-type="fig"}). Indeed, the mechanism by which a PR programme benefits COPD LTx recipients is multifactorial and difficult to define; however, some favourable alterations to cognitive function have been noted on the effects of exercise \[[@C62], [@C63]\]. Exercise training may mitigate COPD-related adverse effects on cognitive function both by improving low arterial oxygen levels, elevated carbon dioxide tension and systemic inflammation \[[@C64], [@C65]\], and by increasing cerebral neural activation through body activity \[[@C66]--[@C68]\].

However, since most of our LTx recipients were not hypoxaemic or hypercapnic and the 3-week PR duration could not be an adequate time period to cause, through exercise, long-term vascular adaptations (*e.g.* improved vascular physiology and neurovascular coupling) \[[@C69]\], which in turn could offer long-term benefits in brain health, the observed improvements in cognitive function cannot be explained solely by the short-term exercise adaptations. Moreover, we did not detect any significant correlation between changes in exercise capacity (6MWT) and changes in the performance of several cognitive domains ([supplementary figure S2](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)). Nevertheless, we believe that the favourable effect on cognitive function after our PR programme can likely be mostly attributed to a cumulative result of improvements rather than a single-factor outcome \[[@C70]\]. Improvements in lung function and physiological indices ([table 2](#TB2){ref-type="table"}) along with potentially improved mental health (mood and self-efficacy) after the completion of the associated intervention, even though short term, may increase the levels of arousal, confidence and energy, and thus set the stage for individuals to meet and overcome task demands \[[@C71], [@C72]\].

Interestingly, one further novelty of the current study is that we detected differences in the effectiveness of PR on cognitive function after stratification by single or bilateral transplantation ([figure 2b](#F2){ref-type="fig"}). The cognitive domains that improved after PR in both single and bilateral LTx recipients were learning skills, memory ability and psychomotor speed, but it seems that bilateral LTx recipients improved more likely because they were younger and had better baseline lung function ([supplementary table S4](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00060-2019.figures-only#fig-data-supplementary-materials)) \[[@C73]\]. However, both single and bilateral LTx recipients presented similar improvements in 6MWD, confirming previous findings from our laboratory \[[@C19]\]. Obviously, future trials are needed to investigate potential changes in the effectiveness of PR between single and bilateral LTx recipients.

Implications and future perspectives {#s4b}
------------------------------------

The findings of the current study may promote the value of PR in COPD LTx recipients as they demonstrate improvements not only in functional status but also in cognitive function, which is a critical factor for optimal post-operative outcomes \[[@C21], [@C22]\]. Indeed, we believe that the effect of our PR programme, even though of only 3 weeks duration, could be strong enough to make a difference in the post-transplant phase of COPD LTx recipients. Additionally, our study may provide information that will be helpful in designing future relevant studies with large cohorts of LTx recipients.

Study limitations {#s4c}
-----------------

The small number of LTx recipients (n=24) in the current pilot study did not provide us with a wider distribution of values regarding the beneficial effects of PR in health, functional and cognitive status. Moreover, a typical 3-week PR programme (the standard PR duration covered by insurance in Germany) may reflect only the short-term PR effects in LTx as smaller but clinically significant improvements have been found to be continued in the second month of PR in LTx recipients \[[@C47]\]. Nevertheless, we detected significant benefits in health, functional and cognitive status of LTx recipients even after this short-term PR programme. Moreover, peripheral muscle strength was not assessed even though quadriceps strength has been described as an independent predictor of exercise performance post-transplantation \[[@C74]\]. Another limitation of this study is the different time intervals from LTx to PR admission across some participants (ranging from 1 to 294 months; median 17 months). Nevertheless, we assessed baseline cognitive evaluation just before PR engagement and immediately after PR completion in all cases. Additionally, we controlled for the effect of different time intervals to PR admission after LTx by stratifying participants in different groups, demonstrating that the PR effect has a significant positive directional trend in all groups, irrespective of the time interval between LTx and PR engagement ([table 4](#TB4){ref-type="table"}).

Despite these limitations and the fact that a number of important clinical questions remain unanswered, including the most effective type of exercise training, the intensity and progression of exercise bouts, and the duration of the PR programme, the current study demonstrates for the first time the benefits of PR in cognitive function of COPD LTx recipients. Further understanding of the impact of the LTx procedure on cognitive function may provide an opportunity to improve post-operative outcomes and prognosis by adopting PR at the post-transplant phase in LTx recipients.

Conclusions {#s4d}
-----------

COPD LTx recipients obtain significant benefits from engagement in a 3-week inpatient PR programme, improving lung function, exercise capacity and specific domains of cognitive function (*e.g.* learning, memory and psychomotor speed) in the post-transplant phase. These improvements may facilitate post-operative treatment and might have a positive impact on prognosis. Therefore, PR programmes, even with a short duration, should be recommended in the post-transplant phase in COPD LTx recipients.
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